[1479683X - European Journal of Endocrinology] Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development.pdf
[en] Testosterone production by the fetal testis depends on a functional relationship between hCG and the LH/chorionic gonadotrophin receptor (LHCGR). Failure of the receptor to correctly respond to its ligand leads to impaired sexual differentiation in males. A phenotypically-female patient with pubertal delay, had a 46,XY karyotype and was diagnosed with 46X,Y disorder of sex development (DSD). Novel compound heterozygous LHCGR mutations were found in the signal peptide: a duplication p.L10_Q17dup of maternal origin, and a deletion (p.K12_L15del) and a p.L16Q missense mutation of paternal origin. cAMP production was very low for both the deletion and duplication mutations and was halved for the missense mutant. The duplication and missense mutations were both expressed intracellularly, but at very low levels at the cell membrane; they were most likely retained in the endoplasmic reticulum. The deletion mutant had a very limited intracellular expression, indicating impaired biosynthesis. There was reduced expression of all three mutants, which was most marked for the deletion mutation. There was also decreased protein expression of all three mutant receptors. In the deletion mutation, the presence of a lower molecular weight band corresponding to LHCGR monomer, probably due to lack of glycosylation, and a lack of bands corresponding to dimers/oligomers suggests absent ER entry. This novel case of 46X,Y DSD illustrates how three different LHCGR signal peptide mutations led to complete receptor inactivation by separate mechanisms. The study underlines the importance of specific regions of signal peptides and expands the spectrum of LHCGR mutations.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
NECHIFOR - POTORAC, Iulia ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'endocrinologie clinique
Trehan, Ashutosh
Szymanska, Kamila
FUDVOYE, Julie ; Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie
THIRY, Albert ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Service d'anatomie et cytologie pathologiques
Huhtaniemi, Ilpo T.
Daly, Adrian ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Beckers, Albert ; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Parent, Anne-Simone ; Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie
Rivero-Muller, Adolfo
Language :
English
Title :
Compound heterozygous mutations in the luteinizing hormone receptor signal peptide causing 46,XY disorder of sex development.
Cahoreau C, Klett D & Combarnous Y. Structure-function relationships of glycoprotein hormones and their subunits' ancestors. Frontiers in Endocrinology 2015 6 26. (https://doi. org/10.3389/fendo.2015.00026)
Vassart G, Pardo L & Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends in Biochemical Sciences 2004 29 119-126. (https://doi.org/10.1016/j.tibs.2004.01.006)
Katritch V, Cherezov V & Stevens RC. Structure-function of the G protein-coupled receptor superfamily. Annual Review of Pharmacology and Toxicology 2013 53 531-556. (https://doi.org/10.1146/annurev-pharmtox-032112-135923)
Teerds KJ & Huhtaniemi IT. Morphological and functional maturation of Leydig cells: from rodent models to primates. Human Reproduction Update 2015 21 310-328. (https://doi.org/10.1093/humupd/dmv008)
Potorac I, Rivero-Müller A, Trehan A, Kiełbus M, Jozwiak K, Pralong F, Hafidi A, Thiry A, Ménagé JJ, Huhtaniemi I et al. A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation. Journal of Endocrinology 2016 231 197-207. (https://doi. org/10.1530/JOE-16-0384)
Achard C, Courtillot C, Lahuna O, Méduri G, Soufir JC, Lière P, Bachelot A, Benyounes H, Schumacher M, Kuttenn F et al. Normal spermatogenesis in a man with mutant luteinizing hormone. New England Journal of Medicine 2009 361 1856-1863. (https://doi. org/10.1056/NEJMoa0805792)
Valdes-Socin H, Salvi R, Daly AF, Gaillard RC, Quatresooz P, Tebeu PM, Pralong FP & Beckers A. Hypogonadism in a patient with a mutation in the luteinizing hormone beta-subunit gene. New England Journal of Medicine 2004 351 2619-2625. (https://doi. org/10.1056/NEJMoa040326)
Song JW, Hwang HJ, Lee CM, Park GH, Kim CS, Lee SJ & Ihm SH. Hypogonadotrophic hypogonadism due to a mutation in the luteinizing hormone β-subunit gene. Korean Journal of Internal Medicine 2018 33 638-641. (https://doi.org/10.3904/kjim.2015.373)
Lofrano-Porto A, Barra GB, Giacomini LA, Nascimento PP, Latronico AC, Casulari LA & da Rocha Neves Fde A. Luteinizing hormone beta mutation and hypogonadism in men and women. New England Journal of Medicine 2007 357 897-904. (https://doi. org/10.1056/NEJMoa071999)
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF & Jameson JL. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. New England Journal of Medicine 1992 326 179-183. (https://doi.org/10.1056/ NEJM199201163260306)
Basciani S, Watanabe M, Mariani S, Passeri M, Persichetti A, Fiore D, Scotto d'Abusco A, Caprio M, Lenzi A, Fabbri A et al. Hypogonadism in a patient with two novel mutations of the luteinizing hormone β-subunit gene expressed in a compound heterozygous form. Journal of Clinical Endocrinology and Metabolism 2012 97 3031-3038. (https:// doi.org/10.1210/jc.2012-1986)
Huhtaniemi IT & Themmen APN. Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine 2005 26 207-217. (https://doi.org/10.1385/ENDO:26:3:207)
Ascoli M, Fanelli F & Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocrine Reviews 2002 23 141-174. (https://doi.org/10.1210/edrv.23.2.0462)
Troppmann B, Kleinau G, Krause G & Gromoll J. Structural and functional plasticity of the luteinizing hormone/ choriogonadotrophin receptor. Human Reproduction Update 2013 19 583-602. (https://doi.org/10.1093/humupd/dmt023)
Kremer H, Mariman E, Otten BJ, Moll GW, Stoelinga GB, Wit JM, Jansen M, Drop SL, Faas B & Ropers HH. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Human Molecular Genetics 1993 2 1779-1783. (https://doi.org/10.1093/hmg/2.11.1779)
Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T & Cutler GB. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993 365 652-654. (https://doi.org/10.1038/365652a0)
Themmen APN & Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine Reviews 2000 21 551-583. (https://doi.org/10.1210/edrv.21.5.0409)
Rivero-Müller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH & Huhtaniemi I. Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. PNAS 2010 107 2319-2324. (https://doi.org/10.1073/ pnas.0906695106)
Trehan A, Kiełbus M, Czapinski J, Stepulak A, Huhtaniemi I & Rivero- Müller A. REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering. Scientific Reports 2016 6 19121. (https://doi.org/10.1038/srep19121)
Trehan A, Rotgers E, Coffey ET, Huhtaniemi I & Rivero-Müller A. CANDLES, an assay for monitoring GPCR induced cAMP generation in cell cultures. Cell Communication and Signaling 2014 12 70. (https://doi.org/10.1186/s12964-014-0070-x)
Peper JS, Brouwer RM, van Leeuwen M, Schnack HG, Boomsma DI, Kahn RS & Hulshoff Pol HE. HPG-axis hormones during puberty: a study on the association with hypothalamic and pituitary volumes. Psychoneuroendocrinology 2010 35 133-140. (https://doi. org/10.1016/j.psyneuen.2009.05.025)
Bliss SP, Navratil AM, Xie J & Roberson MS. GnRH signaling, the gonadotrope and endocrine control of fertility. Frontiers in Neuroendocrinology 2010 31 322-340. (https://doi.org/10.1016/j. yfrne.2010.04.002)
Rivero-Müller A, Potorac I, Pintiaux A, Daly AF, Thiry A, Rydlewski C, Nisolle M, Parent AS, Huhtaniemi I & Beckers A. A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1. European Journal of Endocrinology 2015 172 K27-K36. (https://doi. org/10.1530/EJE-14-1095)
Cools M, Drop SLS, Wolffenbuttel KP, Oosterhuis JW & Looijenga LHJ. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocrine Reviews 2006 27 468-484. (https://doi.org/10.1210/er.2006-0005)
van der Zwan YG, Biermann K, Wolffenbuttel KP, Cools M & Looijenga LHJ. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. European Urology 2015 67 692-701. (https://doi.org/10.1016/j.eururo.2014.07.011)
Martoglio B & Dobberstein B. Signal sequences: more than just greasy peptides. Trends in Cell Biology 1998 8 410-415 [doi:10.1016/S0962-8924(98)01360-9].
Hegde RS & Bernstein HD. The surprising complexity of signal sequences. Trends in Biochemical Sciences 2006 31 563-571. (https:// doi.org/10.1016/j.tibs.2006.08.004)
Schülein R, Westendorf C, Krause G & Rosenthal W. Functional significance of cleavable signal peptides of G protein-coupled receptors. European Journal of Cell Biology 2012 91 294-299. (https:// doi.org/10.1016/j.ejcb.2011.02.006)
Karamyshev AL, Patrick AE, Karamysheva ZN, Griesemer DS, Hudson H, Tjon-Kon-Sang S, Nilsson I, Otto H, Liu Q, Rospert S et al. Inefficient SRP interaction with a nascent chain triggers a mRNA quality control pathway. Cell 2014 156 146-157. (https://doi. org/10.1016/j.cell.2013.12.017)
Wu SM, Hallermeier KM, Laue L, Brain C, Berry AC, Grant DB, Griffin JE, Wilson JD, Cutler GB & Chan WY. Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. Molecular Endocrinology 1998 12 1651-1660. (https://doi.org/10.1210/ mend.12.11.0189)
Richter-Unruh A, Martens JWM, Verhoef-Post M, Wessels HT, Kors WA, Sinnecker GHG, Boehmer A, Drop SLS, Toledo SPA, Brunner HG et al. Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clinical Endocrinology 2002 56 103-112. (https://doi.org/10.1046/j.0300-0664.2001.01437.x)
Wu SM, Jose M, Hallermeier K, Rennert OM & Chan WY. Polymorphisms in the coding exons of the human luteinizing hormone receptor gene. Human Mutation 1998 11 333-334. (https://doi.org/10.1002/(SICI)1098-1004(1998)11:4<333::AID-HUMU19>3.0.CO;2-D)
Rodien P, Cetani F, Costagliola S, Tonacchera M, Duprez L, Minegishi T, Govaerts C & Vassart G. Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. Journal of Clinical Endocrinology and Metabolism 1998 83 4431-4434. (https:// doi.org/10.1210/jcem.83.12.5325)
Piersma D, Berns EMJJ, Verhoef-Post M, Uitterlinden AG, Braakman I, Pols HAP & Themmen APN. A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients. Journal of Clinical Endocrinology and Metabolism 2006 91 1470-1476. (https://doi.org/10.1210/jc.2005-2156)
Schmitz CR, Souza CA, Genro VK, Matte U, Conto Ed & Cunha- Filho JS. LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility. Journal of Assisted Reproduction and Genetics 2015 32 991-997. (https://doi.org/10.1007/s10815-015-0477-3)
Bentov Y, Kenigsberg S & Casper RF. A novel luteinizing hormone/ chorionic gonadotropin receptor mutation associated with amenorrhea, low oocyte yield, and recurrent pregnancy loss. Fertility and Sterility 2012 97 1165-1168. (https://doi.org/10.1016/j. fertnstert.2012.02.002)
Mitri F, Bentov Y, Behan LA, Esfandiari N & Casper RF. A novel compound heterozygous mutation of the luteinizing hormone receptor-implications for fertility. Journal of Assisted Reproduction and Genetics 2014 31 787-794. (https://doi.org/10.1007/s10815-014-0249-5)
Vezzoli V, Duminuco P, Vottero A, Kleinau G, Schülein R, Minari R, Bassi I, Bernasconi S, Persani L & Bonomi M. A new variant in signal peptide of the human luteinizing hormone receptor (LHCGR) affects receptor biogenesis causing leydig cell hypoplasia. Human Molecular Genetics 2015 24 6003-6012. (https://doi.org/10.1093/hmg/ddv313)
Reiersen H & Rees AR. The hunchback and its neighbours: proline as an environmental modulator. Trends in Biochemical Sciences 2001 26 679-684. (https://doi.org/10.1016/S0968-0004(01)01957-0)